This year of Biocat’s 15th anniversary brought a passing of the baton at the helm of the organization to Robert Fabregat. Learn more about his first months, the areas he wants to strengthen, how he imagines the BioRegion a few years from now, and his healthy habits
There are around 100 startups in the BioRegion of Catalonia led and/or founded by women, representing such diverse fields as biotechnology, medical technologies, digital health and investment, among others. To commemorate the International Day of Women and Girls in Science on February 11, we have interviewed ten women entrepreneurs from the BioRegion who have launched a company within the past three years.
Last March, the SARS-CoV-2 pandemic put mobility and social life on hold in most of the world, however in biotech and healthcare, things didn’t stop at all. It was just the opposite, in fact, with activity ramping up. But the pandemic has forced the sector to turn to new ways of working and, in some cases, seem they’re here to stay.
At the time of this pandemic that we live in, in which meetings and presentations are made virtually, pitch preparation is key. We detail some aspects to take into account when presenting your idea to worldwide investors and future clients.
Clara Campàs, partner and co-founder of specialized venture capital fund Asabys Partners, analyzes how the global Covid-19 crisis is affecting the sector and is optimistic about the future of investment in healthcare.
Joël Jean-Mairet, managing partner of Ysios Capital, explained how he sees this crisis from the perspective of a venture capital fund and warns that continued investment in healthcare innovation is more necessary than ever.
Dr. Marta-Gaia Zanchi, founder and managing partner of Nina Capital, explains how the Covid-19 pandemic could affect investment in digital health and medical technology.
Montserrat Vendrell, partner in the Alta Life Sciences investment fund, explains how investors are experiencing the Covid-19 pandemic and highlights one of the few positives that may come out of this crisis: new opportunities in the healthcare sector.
Lluís Pareras, founding partner of the new fund Invivo Ventures, is optimistic about the future of the life sciences sector and warns that companies need to keep working at a good pace these months so they don’t lose inertia.